Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

We only have this paper's title and publication details.

First-in-human trial finds safety for glucocorticoid-induced TNF receptor agonist in advanced tumors, suggesting potential for further studies.